Monday, October 16, 2017 12:18 AM
(NYSE: AGN) and its subsidiaries announced Thursday that the company has reached an agreement with InnoPharma Inc. resolving patent litigation regarding U.S. patents covering its Restasis dry eye drug, which are Orange book-listed and will expire on August 27, 2024.
Wednesday, October 11, 2017 12:36 AM
DENVER—Tomorrow Oct. 12 is World Sight Day, when leading North American optometric companies, networks, schools and practices will once again join a coalition led by Optometry Giving Sight
in support of World Sight Day and the World Sight Day Challenge
, which runs through October, according to an announcement from Optometry Giving Sight.
Wednesday, October 11, 2017 12:33 AM
SACRAMENTO, Calif.—California Governor Jerry Brown signed legislation that proponents say will expand the practice of optometry in the state.
Friday, October 6, 2017 12:27 AM
DUBLIN—The move by Allergan plc
(NYSE: AGN) to transfer patents for the dry eye treatment Restasis to New York’s Saint Regis Mohawk Tribe is going to be investigated by the House’s Committee on Oversight and Government Reform.
Wednesday, October 4, 2017 12:27 AM
DUBLIN—Two major pharma companies—Allergan plc
and Shire plc
—are now involved in a lawsuit related to the marketing of their drugs, Restasis and Xiidra.
Wednesday, October 4, 2017 12:18 AM
NEW YORK—Lighthouse Guild
celebrated its move to a new location and unveiled a new logo at a ribbon-cutting ceremony on Sept. 28.
Friday, September 29, 2017 12:21 AM
ALPHARETTA, Ga.—The lens design used for NaturalVue Multifocal 1 Day Contact Lenses has been shown to fully reverse previously induced myopia in an animal model (chickens), according to research published in the September edition of Ophthalmic and Physiological Optics.
Monday, September 25, 2017 12:30 AM
GRAND RAPIDS, Mich.—Art Optical Contact Lens
, a leading independent custom lens manufacturer, has received 510(k) clearance from the U.S. Food and Drug Administration
(FDA) on their Ampleye scleral lens for the therapeutic management of ocular surface disease from dry eye.
Friday, September 15, 2017 12:15 AM
NILES, Ill. and BIRMINGHAM, Mich.—M&S Technologies
and MacuHealth, LP
have entered into a cooperative marketing agreement. The two companies issued a statement saying they will educate and train eyecare professionals on the direct relationship between enriching macular pigment with nutritional supplements and optimizing visual performance.
Friday, September 8, 2017 12:15 AM
SANTA ANA, Calif.—Johnson & Johnson Vision
has completed its previously announced acquisition of TearScience Inc.,
a medical device manufacturer that focuses on evaluating meibomian gland health and treating Meibomian Gland Dysfunction (MGD), the leading cause of dry eye disease.
Monday, September 4, 2017 12:24 AM
CHARLESTON, S.C.—A South Carolina couple filed a lawsuit against Amazon Inc.
last week in federal district court
here, claiming that the online retailer sold faulty glasses that were marketed as being safe for viewing the solar eclipse in mid-August.
Monday, September 4, 2017 12:21 AM
the leading volunteer eye health and safety organization in the U.S., oversaw the administration of vision-screening training and certification at a professional development meeting for Philadelphia school nurses held here Friday.
Wednesday, August 23, 2017 12:30 AM
DUBLIN, Calif. and JENA, Germany—Zeiss
has acquired Veracity Innovations, a medical software company in Temple, Texas. The purchase price was not disclosed.